透析患者血浆钾浓度的波动
透析患者因肾功能丧失,血浆钾稳态受损,常规每周三次透析虽可实现长期总钾平衡,但间歇性治疗导致血浆钾浓度大幅波动,增加心律失常风险。多种透析及非透析干预可减小波动幅度,但对临床结局的影响尚不明确。
要点
- 透析患者血浆钾波动大,与心律失常风险增加相关
- 每周三次透析可维持长期总钾平衡但无法避免间期波动
- 干预可减小钾波动幅度,但临床获益尚未证实
核心结论
- 透析患者因间歇性治疗导致血浆钾浓度大幅波动,增加心律失常风险,干预对临床结局的影响尚不明确。
主要发现
- 终末期肾病患者因肾功能丧失,维持正常钾平衡的能力下降。
- 常规每周三次透析可实现长期总钾质量平衡,但间歇性治疗导致血浆钾浓度大幅波动。
- 血浆钾波动可能增加心律失常风险。
- 多种透析和非透析干预可减小血浆钾波动幅度,但对临床结局的影响尚不明确。
临床怎么用
- 关注透析患者血浆钾波动,考虑干预以减小波动幅度,但需认识到临床获益尚未证实。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Plasma potassium concentration is maintained in a narrow range to avoid deleterious electrophysiologic consequences of both abnormally low and high levels. This is achieved by redundant physiologic mechanisms, with the kidneys playing a central role in maintaining both short-term plasma potassium stability and long-term total body potassium balance. In patients with end-stage renal disease, the lack of kidney function reduces the body's ability to maintain normal physiologic potassium balance. Routine thrice-weekly dialysis therapy achieves long-term total body potassium mass balance, but the intermittent nature of dialytic therapy can result in wide fluctuations in plasma potassium concentration and consequently contribute to an increased risk of arrhythmogenicity. Various dialytic and nondialytic interventions can reduce the magnitude of these fluctuations, but the impact of such interventions on clinical outcomes remains unclear.
引用
- Kovesdy CP. Fluctuations in plasma potassium in patients on dialysis. Nephrol Dial Transplant. 2019. PMID: 31800082. doi:10.1093/ndt/gfz209
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。